SLC24A4

gene
On this page

Also known as NCKX4

Summary

SLC24A4 (solute carrier family 24 member 4, HGNC:10978) is a protein-coding gene on chromosome 14q32.12, encoding Sodium/potassium/calcium exchanger 4 (Q8NFF2). Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+).

This gene encodes a sodium/potassium/calcium exchange protein. The encoded antiporter transports one calcium and one potassium ion in exchange for four sodium ions and has been implicated in amelogenesis and enamel maturation. Certain variants in this gene have been associated with skin, hair, and eye pigmentation, while other variants have been identified in people with hypomaturation-type amelogenesis imperfecta.

Source: NCBI Gene 123041 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): amelogenesis imperfecta hypomaturation type 2A5 (Strong, GenCC) — +2 more curated relationships
  • GWAS associations: 38
  • Clinical variants (ClinVar): 186 total — 5 pathogenic
  • Phenotypes (HPO): 7
  • Druggable target: yes
  • MANE Select transcript: NM_153646

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:10978
Approved symbolSLC24A4
Namesolute carrier family 24 member 4
Location14q32.12
Locus typegene with protein product
StatusApproved
AliasesNCKX4
Ensembl geneENSG00000140090
Ensembl biotypeprotein_coding
OMIM609840
Entrez123041

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 6 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000393265, ENST00000525557, ENST00000526482, ENST00000531433, ENST00000532405, ENST00000554461, ENST00000554925, ENST00000556739, ENST00000676001

RefSeq mRNA: 5 — MANE Select: NM_153646 NM_001378620, NM_001425254, NM_153646, NM_153647, NM_153648

CCDS: CCDS45155, CCDS45156, CCDS9903

Canonical transcript exons

ENST00000532405 — 17 exons

ExonStartEnd
ENSE000017045689244208992442173
ENSE000017582819244340092443474
ENSE000017917939244271392442816
ENSE000021912059232316592323960
ENSE000034898459244531792445342
ENSE000035011179243933592439409
ENSE000035067939248666692486780
ENSE000035644759245390092454069
ENSE000035709979232586892325978
ENSE000036017169249217592492240
ENSE000036204179243391292433988
ENSE000036245789244907492449216
ENSE000036320409249166592491777
ENSE000036624839248268092482846
ENSE000036708629244737192447424
ENSE000036825609245640492456608
ENSE000037464649249347692501481

Expression profiles

Bgee: expression breadth ubiquitous, 168 present calls, max score 89.47.

FANTOM5 (CAGE): breadth broad, TPM avg 1.3040 / max 86.3141, expressed in 219 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1410851.2744218
1410840.029617

Top tissues by expression

243 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
monocyteCL:000057689.47gold quality
leukocyteCL:000073888.87gold quality
primary visual cortexUBERON:000243683.73gold quality
middle temporal gyrusUBERON:000277183.23gold quality
sural nerveUBERON:001548883.02gold quality
Brodmann (1909) area 23UBERON:001355482.60gold quality
bloodUBERON:000017881.63gold quality
granulocyteCL:000009481.45gold quality
endothelial cellCL:000011579.90silver quality
occipital lobeUBERON:000202179.53gold quality
buccal mucosa cellCL:000233678.81silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099178.49gold quality
ponsUBERON:000098877.18gold quality
medial globus pallidusUBERON:000247776.92gold quality
globus pallidusUBERON:000187575.98gold quality
tibial nerveUBERON:000132374.60gold quality
postcentral gyrusUBERON:000258174.33gold quality
superior frontal gyrusUBERON:000266173.96gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047373.80gold quality
right frontal lobeUBERON:000281073.61gold quality
prefrontal cortexUBERON:000045173.28gold quality
Brodmann (1909) area 9UBERON:001354073.08gold quality
corpus callosumUBERON:000233673.06gold quality
frontal cortexUBERON:000187073.04gold quality
substantia nigra pars compactaUBERON:000196572.66gold quality
medulla oblongataUBERON:000189672.23gold quality
dorsolateral prefrontal cortexUBERON:000983472.14gold quality
midbrainUBERON:000189172.02gold quality
substantia nigraUBERON:000203872.01gold quality
parietal lobeUBERON:000187271.89gold quality

Single-cell (SCXA)

Detected in 6 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-75367yes64.75
E-GEOD-137537yes18.07
E-ANND-3yes4.64
E-GEOD-111727no212.80
E-CURD-11no6.46
E-MTAB-5061no2.24

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

283 targeting SLC24A4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-12118100.0065.881270
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-3163100.0077.238605
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-3689D100.0066.141181
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-4692100.0067.322066
HSA-MIR-4455100.0065.481587
HSA-MIR-4283100.0066.422097
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-118499.9968.191458
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-548AW99.9972.573559
HSA-MIR-451499.9967.101870
HSA-MIR-453499.9966.581907
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-27A-3P99.9872.132955

Literature-anchored findings (GeneRIF, showing 13)

  • identification and sequencing, as well as mapping to chromosomal region 14q32 (PMID:12379639)
  • IRF4 and SLC24A4 loci are associated with human hair color and skin pigmentation. (PMID:18483556)
  • Taken together, these data demonstrate a potentially important role for NCX1 in control of Ca2+ homeostasis and link store depletion via STIM1 directly with NCX activation. (PMID:21126331)
  • These findings support a key role for SLC24A4 in calcium transport during enamel formation. (PMID:23375655)
  • enamel maturation is dependent upon STIM1 and SLC24A4 function, and that there are important differences in the Ca(2+) transcellular transport systems used by secretory- and maturation-stage ameloblasts. (PMID:24621671)
  • Brain DNA methylation in sLC24A4 was associated with pathological Alzheimer disease. (PMID:25365775)
  • The expressions of NCX1 and NCKX4 were significantly higher in the patent ductus arteriosus group at both the protein and mRNA levels. (PMID:25500693)
  • pigment cells express robust, functional NCKX4 activity (PMID:27093457)
  • mutations in SLC24A4 and SLC24A5 are responsible for the phenotypic defects observed in human amylogenesis imperfecta and non-syndromic oculocutaneous albinism patients. (PMID:27129268)
  • no significant relation was noted between SLC24A4 rs10498633 and late-onset Alzheimer;s disease risk in neither apolipoprotein E (APOE) epsilon4 carriers nor non-carriers after adjusting for age and gender (PMID:27215332)
  • This nonsense sequence variant c.1192C > T (p.Gln398*) is the sixth disease-causing variant in SLC24A4, which extends its mutation spectrum and confirms the role of this gene in the morphogenesis of human tooth enamel. The identified variant highlights the critical role of SLC24A4 in causing a rare Amelogenesis imperfecta (AI) type in humans. (PMID:32380970)
  • Association between brown eye colour in rs12913832:GG individuals and SNPs in TYR, TYRP1, and SLC24A4. (PMID:32915910)
  • Calmodulin binds and modulates K(+)-dependent Na(+)/Ca(2+)-exchanger isoform 4, NCKX4. (PMID:33199372)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_rerioslc24a4aENSDARG00000015425
danio_rerioslc24a4bENSDARG00000067509
mus_musculusSlc24a4ENSMUSG00000041771
rattus_norvegicusSlc24a4ENSRNOG00000006729
drosophila_melanogasterCG17167FBGN0039941
drosophila_melanogasterCG12061FBGN0040031
drosophila_melanogasterzydFBGN0265767

Paralogs (4): SLC24A1 (ENSG00000074621), SLC24A2 (ENSG00000155886), SLC24A3 (ENSG00000185052), SLC24A5 (ENSG00000188467)

Protein

Protein identifiers

Sodium/potassium/calcium exchanger 4Q8NFF2 (reviewed: Q8NFF2)

Alternative names: Na(+)/K(+)/Ca(2+)-exchange protein 4, Solute carrier family 24 member 4

All UniProt accessions (3): Q8NFF2, G3V505, H0YCX3

UniProt curated annotations — full annotation on UniProt →

Function. Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+). Controls the rapid response termination and proper regulation of adaptation in olfactory sensory neurons (OSNs) which subsequently influences how odor information is encoded and perceived. May play a role in calcium transport during amelogenesis.

Subcellular location. Cell membrane. Cytoplasm.

Tissue specificity. Expressed abundantly in all regions of the brain, aorta, lung and thymus. Expressed at lower levels in the stomach and intestine.

Disease relevance. Amelogenesis imperfecta, hypomaturation type, 2A5 (AI2A5) [MIM:615887] A defect of enamel formation. The disorder involves both primary and secondary dentitions. The teeth have a shiny agar jelly appearance and the enamel is softer than normal. Brown pigment is present in middle layers of enamel. The disease is caused by variants affecting the gene represented in this entry.

Polymorphism. Genetic variants in SLC24A4 define the skin/hair/eye pigmentation variation locus 6 (SHEP6) [MIM:210750]. Hair, eye and skin pigmentation are among the most visible examples of human phenotypic variation, with a broad normal range that is subject to substantial geographic stratification. In the case of skin, individuals tend to have lighter pigmentation with increasing distance from the equator. By contrast, the majority of variation in human eye and hair color is found among individuals of European ancestry, with most other human populations fixed for brown eyes and black hair.

Similarity. Belongs to the Ca(2+):cation antiporter (CaCA) (TC 2.A.19) family. SLC24A subfamily.

Isoforms (4)

UniProt IDNamesCanonical?
Q8NFF2-11yes
Q8NFF2-22
Q8NFF2-33
Q8NFF2-44

RefSeq proteins (5): NP_001365549, NP_001412183, NP_705932, NP_705933, NP_705934 (=MANE)

Domains & families (InterPro)

IDNameType
IPR004481K/Na/Ca-exchangerFamily
IPR004837NaCa_ExmembDomain
IPR044880NCX_ion-bd_dom_sfHomologous_superfamily

Pfam: PF01699

Catalyzed reactions (Rhea), 1 shown:

  • Ca(2+)(out) + K(+)(out) + 4 Na(+)(in) = Ca(2+)(in) + K(+)(in) + 4 Na(+)(out) (RHEA:69967)

UniProt features (43 total): topological domain 11, transmembrane region 10, sequence variant 7, splice variant 4, repeat 2, compositionally biased region 2, glycosylation site 2, sequence conflict 2, signal peptide 1, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NFF2-F170.840.16

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 69, 76

Function

Pathways and Gene Ontology

Reactome pathways

8 pathways

IDPathway
R-HSA-425561Sodium/Calcium exchangers
R-HSA-5619055Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)
R-HSA-1643685Disease
R-HSA-382551Transport of small molecules
R-HSA-425393
R-HSA-425407SLC-mediated transmembrane transport
R-HSA-5619102SLC transporter disorders
R-HSA-5619115Disorders of transmembrane transporters

MSigDB gene sets: 263 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP, GOBP_POTASSIUM_ION_TRANSPORT, GOBP_RESPONSE_TO_NITROGEN_COMPOUND, YAATNRNNNYNATT_UNKNOWN, BENPORATH_ES_WITH_H3K27ME3, GOBP_BEHAVIOR, GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, TGCACTT_MIR519C_MIR519B_MIR519A, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_PHOTOTRANSDUCTION, TGACCTY_ERR1_Q2, LHX3_01

GO Biological Process (29): monoatomic ion transport (GO:0006811), intracellular calcium ion homeostasis (GO:0006874), phototransduction (GO:0007602), sensory perception of smell (GO:0007608), regulation of G protein-coupled receptor signaling pathway (GO:0008277), response to high light intensity (GO:0009644), positive regulation of gene expression (GO:0010628), olfactory nerve maturation (GO:0021630), sodium ion transmembrane transport (GO:0035725), cone photoresponse recovery (GO:0036368), drinking behavior (GO:0042756), negative regulation of calcium-mediated signaling (GO:0050849), detection of chemical stimulus involved in sensory perception of smell (GO:0050911), calcium ion homeostasis (GO:0055074), enamel mineralization (GO:0070166), calcium ion transmembrane transport (GO:0070588), cellular response to high light intensity (GO:0071486), potassium ion transmembrane transport (GO:0071805), membrane repolarization (GO:0086009), amelogenesis (GO:0097186), calcium ion import across plasma membrane (GO:0098703), regulation of eating behavior (GO:1903998), calcium ion export across plasma membrane (GO:1990034), response to melanocyte-stimulating hormone (GO:1990680), response to odorant (GO:1990834), potassium ion transport (GO:0006813), sodium ion transport (GO:0006814), calcium ion transport (GO:0006816), transmembrane transport (GO:0055085)

GO Molecular Function (6): calcium channel activity (GO:0005262), calmodulin binding (GO:0005516), calcium, potassium:sodium antiporter activity (GO:0008273), symporter activity (GO:0015293), calcium-dependent protein binding (GO:0048306), antiporter activity (GO:0015297)

GO Cellular Component (7): cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), apical plasma membrane (GO:0016324), vesicle (GO:0031982), cone photoreceptor outer segment (GO:0120199), cell periphery (GO:0071944)

Reactome top-level categories

Rollup of top-5 pathways:

CategoryPathways
Metal ion SLC transporters1
SLC transporter disorders1
Transport of small molecules1
Disorders of transmembrane transporters1
Disease1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
monoatomic cation transmembrane transport3
cellular anatomical structure3
protein binding2
secondary active transmembrane transporter activity2
transport1
intracellular monoatomic cation homeostasis1
calcium ion homeostasis1
signal transduction1
detection of light stimulus1
sensory perception of chemical stimulus1
G protein-coupled receptor signaling pathway1
regulation of signal transduction1
response to light intensity1
gene expression1
regulation of gene expression1
positive regulation of macromolecule biosynthetic process1
olfactory nerve development1
cranial nerve maturation1
sodium ion transport1
response to light stimulus1
feeding behavior1
calcium-mediated signaling1
regulation of calcium-mediated signaling1
negative regulation of intracellular signal transduction1
sensory perception of smell1
detection of chemical stimulus involved in sensory perception1
monoatomic cation homeostasis1
inorganic ion homeostasis1
tooth mineralization1
amelogenesis1
calcium ion transport1
response to high light intensity1
cellular response to light intensity1
potassium ion transport1
regulation of membrane potential1
odontogenesis of dentin-containing tooth1
anatomical structure formation involved in morphogenesis1
monoatomic cation channel activity1
calcium ion transmembrane transporter activity1
calcium:sodium antiporter activity1

Protein interactions and networks

STRING

1439 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC24A4TPCN2Q8NHX9914
SLC24A4SLC45A2Q9UMX9854
SLC24A4OCA2Q04671849
SLC24A4ZCWPW1Q9H0M4827
SLC24A4RIN3Q8TB24819
SLC24A4NME8Q8N427785
SLC24A4TYRP14679733
SLC24A4MC1RQ01726731
SLC24A4ASIPP42127723
SLC24A4CASS4Q9NQ75720
SLC24A4TYRP1P17643714
SLC24A4ABCA7Q8IZY2706
SLC24A4IRF4Q15306701
SLC24A4ODAPHQ17RF5696
SLC24A4FERMT2Q96AC1691

IntAct

2 interactions, top by confidence:

ABTypeScore
SLC24A4MYL12Bpsi-mi:“MI:0914”(association)0.350

BioGRID (15): SLC24A4 (Affinity Capture-RNA), SLC24A4 (Affinity Capture-MS), SLC24A4 (Co-fractionation), SPON1 (Co-fractionation), VPS26A (Co-fractionation), ACTA2 (Affinity Capture-MS), ACTG1 (Affinity Capture-MS), CTSD (Affinity Capture-MS), GOLPH3 (Affinity Capture-MS), MYH10 (Affinity Capture-MS), MYL12B (Affinity Capture-MS), PUF60 (Affinity Capture-MS), TMOD3 (Affinity Capture-MS), TMX2 (Affinity Capture-MS), TPM4 (Affinity Capture-MS)

ESM2 similar proteins: A0A096X8J7, A3QM97, A7T1N0, B2RXE2, E9Q3M5, G3X939, G5EBK1, M5A7P9, O13726, O80739, P19334, P26432, P26433, P31662, P32847, P34586, P48764, P48994, P79100, Q01345, Q04121, Q09573, Q14940, Q1ZXJ0, Q28362, Q69RI8, Q6A4L1, Q6AI14, Q6H4R6, Q6RI88, Q84MS3, Q8BJI1, Q8BTY2, Q8BUE1, Q8CFW1, Q8NFF2, Q8T5S1, Q8VIH3, Q93380, Q94225

Diamond homologs: B8K1V7, O22252, O54701, P23685, P32418, P48765, P48766, P48767, P48768, P57103, P70414, P70549, Q01728, Q2R041, Q6H641, Q8BUN9, Q8CGQ8, Q8K596, Q8NFF2, Q99PD7, Q9EPQ0, Q9HC58, Q9UI40, Q9UPR5, Q9VDG5, Q9VN12, S4R2P9, F1NXU8, O04034, O16242, P87122, Q49SH1, Q6AXS0, Q71RS6, Q925Q3, Q9FKP1, Q9FKP2, Q9U6A0, O60721, O46383

SIGNOR signaling

3 interactions.

AEffectBMechanism
SLC24A4“down-regulates quantity”calcium(2+)relocalization
SLC24A4“down-regulates quantity”potassium(1+)relocalization
SLC24A4“up-regulates quantity”sodium(1+)relocalization

Disease & clinical

Clinical variants and AI predictions

ClinVar

186 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic5
Likely pathogenic0
Uncertain significance98
Likely benign27
Benign41

Top pathogenic / likely-pathogenic (5)

Variant IDHGVSClassification
1326286NM_153646.4(SLC24A4):c.613C>T (p.Arg205Ter)Pathogenic
139657NM_153646.4(SLC24A4):c.1015C>T (p.Arg339Ter)Pathogenic
139658NM_153646.4(SLC24A4):c.1495A>T (p.Ser499Cys)Pathogenic
139659NM_153646.4(SLC24A4):c.437C>T (p.Ala146Val)Pathogenic
689492NM_153646.4(SLC24A4):c.1192C>T (p.Gln398Ter)Pathogenic

SpliceAI

3959 predictions. Top by Δscore:

VariantEffectΔscore
14:92325861:A:AGacceptor_gain1.0000
14:92433910:A:AGacceptor_gain1.0000
14:92433910:AGC:Aacceptor_gain1.0000
14:92433911:G:GGacceptor_gain1.0000
14:92433911:GC:Gacceptor_gain1.0000
14:92433911:GCG:Gacceptor_gain1.0000
14:92433987:GT:Gdonor_gain1.0000
14:92442083:TTTCA:Tacceptor_loss1.0000
14:92442087:A:AGacceptor_gain1.0000
14:92442087:AG:Aacceptor_loss1.0000
14:92442088:G:Aacceptor_loss1.0000
14:92442088:G:GGacceptor_gain1.0000
14:92442088:GA:Gacceptor_gain1.0000
14:92442138:G:GTdonor_gain1.0000
14:92442170:ATTGG:Adonor_loss1.0000
14:92442171:TTGGT:Tdonor_loss1.0000
14:92442173:GGTAA:Gdonor_loss1.0000
14:92442174:G:GGdonor_gain1.0000
14:92442174:G:Tdonor_loss1.0000
14:92442175:T:Adonor_loss1.0000
14:92442707:TTCCA:Tacceptor_loss1.0000
14:92442708:TCCA:Tacceptor_loss1.0000
14:92442709:CCA:Cacceptor_loss1.0000
14:92442710:CA:Cacceptor_loss1.0000
14:92442711:A:AGacceptor_gain1.0000
14:92442711:AG:Aacceptor_gain1.0000
14:92442711:AGG:Aacceptor_gain1.0000
14:92442711:AGGG:Aacceptor_gain1.0000
14:92442712:G:GGacceptor_gain1.0000
14:92442712:G:Tacceptor_loss1.0000

AlphaMissense

4085 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:92439393:T:CL126P1.000
14:92442129:T:CM145T1.000
14:92442130:G:AM145I1.000
14:92442130:G:CM145I1.000
14:92442130:G:TM145I1.000
14:92442132:C:AA146D1.000
14:92442134:G:CA147P1.000
14:92442135:C:AA147E1.000
14:92442137:G:AG148R1.000
14:92442137:G:CG148R1.000
14:92442138:G:AG148E1.000
14:92442140:A:CS149R1.000
14:92442142:C:AS149R1.000
14:92442142:C:GS149R1.000
14:92442150:C:AP152Q1.000
14:92442150:C:GP152R1.000
14:92442156:T:CL154P1.000
14:92442752:T:AI173N1.000
14:92442757:G:CG175R1.000
14:92442757:G:TG175C1.000
14:92442758:G:AG175D1.000
14:92442758:G:TG175V1.000
14:92442769:T:CF179L1.000
14:92442771:C:AF179L1.000
14:92442771:C:GF179L1.000
14:92442774:C:AN180K1.000
14:92442774:C:GN180K1.000
14:92443431:G:CR205P1.000
14:92443433:G:CD206H1.000
14:92443434:A:CD206A1.000

dbSNP variants (sampled 300 via entrez): RS1000005176 (14:92469375 G>C,T), RS1000009832 (14:92323011 G>A,C,T), RS1000051723 (14:92360384 T>A), RS1000053802 (14:92454316 A>G), RS1000059066 (14:92473690 C>G), RS1000074746 (14:92354048 C>A,T), RS1000086645 (14:92430721 C>T), RS1000090826 (14:92354849 G>A,T), RS1000132834 (14:92475687 G>A), RS1000163225 (14:92392636 G>A), RS1000188817 (14:92430481 C>T), RS1000195014 (14:92338764 C>T), RS1000195688 (14:92437262 C>G,T), RS1000200979 (14:92421019 T>C), RS1000219831 (14:92412818 A>G)

Disease associations

OMIM: gene MIM:609840 | disease phenotypes: MIM:104500, MIM:615887

GenCC curated gene-disease

DiseaseClassificationInheritance
amelogenesis imperfecta hypomaturation type 2A5StrongAutosomal recessive
amelogenesis imperfecta, type 3ASupportiveAutosomal dominant
amelogenesis imperfecta type 2SupportiveAutosomal recessive

Mondo (4): amelogenesis imperfecta (MONDO:0019507), amelogenesis imperfecta hypomaturation type 2A5 (MONDO:0014385), amelogenesis imperfecta, type 3A (MONDO:0007538), amelogenesis imperfecta type 2 (MONDO:0015048)

Orphanet (1): Amelogenesis imperfecta (Orphanet:88661)

HPO phenotypes

7 total (7 of 7 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000670Carious teeth
HP:0000705Amelogenesis imperfecta
HP:0001595Abnormal hair morphology
HP:0002164Nail dysplasia
HP:0006286Yellow-brown discoloration of the teeth
HP:0011463Childhood onset

GWAS associations

38 associations (top):

StudyTraitp-value
GCST000117_1Blue vs. green eyes4.000000e-38
GCST000118_1Blond vs. brown hair color1.000000e-48
GCST000190_1Black vs. blond hair color8.000000e-21
GCST000707_2Hair color5.000000e-13
GCST000710_3Eye color2.000000e-23
GCST000710_5Eye color1.000000e-16
GCST001066_12Dialysis-related mortality8.000000e-06
GCST001066_5Dialysis-related mortality2.000000e-06
GCST001929_6Eye color4.000000e-11
GCST001929_8Eye color3.000000e-07
GCST001932_4Hair color2.000000e-36
GCST002245_20Alzheimer’s disease (late onset)6.000000e-09
GCST002817_14Alzheimer’s disease in APOE e4- carriers4.000000e-07
GCST003021_5Brown vs. non-brown hair color3.000000e-09
GCST003022_5Light vs. dark hair color3.000000e-10
GCST003023_4Blond vs non-blond hair color3.000000e-10
GCST003996_30Monobrow4.000000e-21
GCST005790_32Rosacea symptom severity5.000000e-06
GCST005965_3B cell acute lymphoblastic leukaemia (normal cytogenetics)6.000000e-09
GCST005966_3B cell acute lymphoblastic leukaemia (hyperdiploid negative)2.000000e-06
GCST005967_3B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)3.000000e-06
GCST006075_19Hair color1.000000e-100
GCST006988_117Blond vs. brown/black hair color1.000000e-09
GCST006988_130Blond vs. brown/black hair color9.000000e-15
GCST006988_142Blond vs. brown/black hair color9.000000e-13
GCST006989_38Brown vs. black hair color3.000000e-128
GCST007319_25Alzheimer’s disease (late onset)1.000000e-07
GCST007319_28Alzheimer’s disease (late onset)2.000000e-08
GCST007320_75Alzheimer’s disease or family history of Alzheimer’s disease2.000000e-10
GCST007320_94Alzheimer’s disease or family history of Alzheimer’s disease2.000000e-07

EFO canonical traits (9, from GWAS)

EFO IDTrait name
EFO:0003949eye color
EFO:0003924hair color
EFO:0007906synophrys measurement
EFO:0009180rosacea severity measurement
EFO:0009268family history of Alzheimer’s disease
EFO:0004611low density lipoprotein cholesterol measurement
EFO:0006834septic shock
EFO:0004530triglyceride measurement
EFO:0007984platelet component distribution width

MeSH disease descriptors (3)

DescriptorNameTree numbers
D000567Amelogenesis ImperfectaC07.650.800.295.250; C07.793.700.295.250; C16.131.850.800.295.250
C536606Amelogenesis Imperfecta hypomaturation type (supp.)
C562880Amelogenesis Imperfecta, Type III (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5209636 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs77441273SLC24A40.000

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC24 family of sodium/potassium/calcium exchangers

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratrolaffects cotreatment, decreases expression, increases expression2
Benzo(a)pyreneaffects methylation, increases mutagenesis2
bisphenol Adecreases expression1
ethyl-p-hydroxybenzoatedecreases expression1
arsenitedecreases methylation1
pentanalincreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608increases reaction, affects binding1
Arsenicaffects methylation1
Atrazineincreases expression1
Copperaffects cotreatment, decreases expression1
Endosulfandecreases expression1
Environmental Pollutantsaffects expression1
Plant Extractsaffects cotreatment, increases expression1
Rotenonedecreases expression1
Silicon Dioxideincreases expression1
Tretinoinincreases expression1
Zidovudineaffects cotreatment, increases expression1
1-Methyl-4-phenylpyridiniumdecreases expression1
Aflatoxin B1decreases methylation1

ChEMBL screening assays

1 unique, capped per target: 1 functional

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5209621FunctionalSubstrate uptake by the Sodium/Potassium/Calcium Exchanger 4 (NCKX4, SLC24A4) as assessed by Screen Questtrade mark Fluo-8 NW calcium assay kit in HEK-293 JumpIN-SLC24A4 cells (PubChem AID: 1794814)Fluo-8 based assay for SLC24A4 using HEK293 JumpIn SLC24A4 OE cells

Clinical trials (associated diseases)

8 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT01746121Not specifiedTERMINATEDAmelogenesis Imperfecta
NCT02994862Not specifiedUNKNOWNE. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent
NCT03810859Not specifiedUNKNOWNNon-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants
NCT04704089Not specifiedRECRUITINGColorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects
NCT04897724Not specifiedUNKNOWNClinical Performance of Composites in Patients With Amelogenesis Imperfecta
NCT04927962Not specifiedCOMPLETEDPsycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta
NCT05343247Not specifiedCOMPLETEDDental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta
NCT07250906Not specifiedRECRUITINGOral Health Related Quality of Life of Children With Amelogenesis Imperfecta